Navigation Links
AutoImmune Inc. Reports 2008 Fourth Quarter and Year End Financial Results
Date:3/16/2009

multiple sclerosis.

AutoImmune also announced today that its Annual Meeting of Shareholders will be held on Friday, May 22, 2009, at 11:00 a.m. EDT, at the offices of Nutter, McClennen & Fish, 155 Seaport Blvd. in Boston, Massachusetts. AutoImmune is a biopharmaceutical company involved in the development of treatments for autoimmune and cell-mediated inflammatory diseases and conditions.

Statements in this release that are not strictly historical are forward-looking statements including statements about clinical trials and studies and future sales, royalties and revenue. You can identify these forward-looking statements because they involve our expectations, beliefs, projections, anticipations or other characterizations of future events or circumstances. These forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that may cause actual results to differ materially from those in the forward-looking statements as a result of any number of factors. These factors include, but are not limited to the uncertainties of clinical trial results, the Company's dependence on third parties for licensing revenue, and the risks of technological change and competition. These factors are more fully discussed, as are other factors, in the Company's most recent Annual Report on Form 10-KSB filed with the Securities and Exchange Commission in the section entitled "Risk Factors."

- Financial Chart Follows -


                                 AUTOIMMUNE INC.
                             STATEMENT OF OPERATIONS
                                   (Unaudited)

                                 Three months ended           Year ended
                                     December 31,            December 31,
                                   2007        2008        2007        2008
                                   ----        ----   
'/>"/>
SOURCE  AutoImmune Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 

Related biology technology :

1. Advances in Detection Technology Drive the European Autoimmune Disease Diagnostics Market
2. AutoImmune Inc. Reports 2008 Third Quarter Financial Results
3. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
4. AutoImmune Inc. Reports 2007 Fourth Quarter and Year End Financial Results
5. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes - Correction
6. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes
7. Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results
8. Dendreon Reports Fourth Quarter and 2008 Year End Financial Results
9. Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
10. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results
11. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...TTLE, Nov. 30 Cell Thera...ed today that its new class of platinum-based anti...ted a stronger anti-tumor potency and activity com...nds as well as the ability to overcome cisplatin-r...presented in a paper titled "Novel Bis-platinum Co...
(Date:11/30/2009)... , AMSTERDAM, November 30 /PRNews...ublisher of scientific, medical and technical prod...ch of Embase, its comprehensive biomedical,databas... more than 7,000,active, peer reviewed journals. ,... advancement of new biomedical,and pharmaceutical ...
(Date:11/27/2009)..., November 27 Stallergen...alair(R) in both adults and children,through a Mut...try where,Oralair(R) has been marketed, was the re... registered in Austria, Belgium, Bulgaria, Cyprus,...ece, Hungary, Ireland, Italy,Latvia, Lithuania, L...
(Date:11/25/2009)...TON, Nov. 25 Biotech firm Replikin... data from the 1918 pandemic through the predictio...emic, today issued its latest biochemical analysis...ty of the H1N1 ("Swine Flu") virus has dropped fro...rrent outbreak in the spring of 2009 to resting no...
Breaking Biology Technology:New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5
...K, Sept. 10 In a major victory for its client,App...g technologies, Weil,Gotshal & Manges LLP won a su...sted life sciences patents. In the action, Enzo Bi...cing reagents and instruments infringed,the patent...Honorable Janet Bond Arterton of the,United States...
...Sept. 10 Sanofi-aventis announced,today a civil s...esolve,"Average Wholesale Price" (AWP) lawsuits un...et(R) involving one of its predecessor companies, ...t relates to government claims that API artificial...increased the cost of,government reimbursements fo...
...POLIS, Sept. 10 BioStorage Technologies, Inc.,(BS...th Indianapolis Power,& Light Company (IPL) to pur...le energy resources, through IPL,s Green Power Opt...ssil-fueled power generation, this,program will be...l by 2009. BST becomes the third-largest customer...
Other Biology Technology:Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents 2BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy 2BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy 3BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy 4
(Date:11/26/2009)... their impressive antlers, red deer have been caug...eer,s antlers are much more than decorative. They ...duelling. John Currey, from The University of York...ies of bone for over half a century and has become... through a long-standing collaboration with Tomas ...
(Date:11/26/2009)...icillin-resistant Staphylococcus Aureus ) and oth... as low-temperature plasma prototype devices have ...iling bactericidal cocktails. , Two prototype de...fection of healthy skin (e.g. hands and feet) in h... a lethal threat; and another to shoot bacteria-ki...
(Date:11/25/2009)...t Larisch, Head of the Cell Death Research Laborat...logy, has been awarded the prestigious Johnson & J...oring the cause of brain cell damage in Parkinson,...o scientists in support of innovation and excellen...ly conferred earlier this month at an event at the...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Eukanuba Unleashes New Free iPhone Application Providing Dog Owners With Instant Access to Dog Parks and Other Four Legged Fun 49737 1Eukanuba Unleashes New Free iPhone Application Providing Dog Owners With Instant Access to Dog Parks and Other Four Legged Fun 49737 2Paulo F Costa Joins MacroGenics Board of Directors 12740 1Paulo F Costa Joins MacroGenics Board of Directors 12740 2Paulo F Costa Joins MacroGenics Board of Directors 12740 3MADIT CRT Trial Meets Primary Endpoint 4632 1MADIT CRT Trial Meets Primary Endpoint 4632 2MADIT CRT Trial Meets Primary Endpoint 4632 3MADIT CRT Trial Meets Primary Endpoint 4632 4
...Tech,s College of Agriculture and Life Sciences ar...scientists that have been awarded $5 million from ...technologies to produce higher quality, disease-re...ensive amount of molecular research has been condu...markers have been used to identify genes controlli...
...number, letter or other shape, neurons in various ...erent components of that shape, almost instantaneo... an image that the individual then "sees" and unde...ty report. , A team from the university,s Zanvyl K...but speedy process in detail in a recent issue of ...
...ic components of living things, are among the most...how proteins form or "fold" from sequenced strings...llenges of biology. , A common belief holds that ...t, the more stable - or less likely to unfold - th...rch issue of Biophysical Journal, a team of chemic...
Other Biology News:Virginia Tech helping to develop higher quality, disease-resistant wheat varieties 2In the mind's eye: How the brain makes a whole out of parts 2UW-Madison engineers squeeze secrets from proteins 2
96 Well Plate Sterile from Thermo Scientific
...he Forma Incubated Console Orbital Shakers combine...g ergonomics, unequalled programming power. The p...m prevents vibration, allowing the unit to run wit...tration system reduces contamination. The heavy s...
HV Mini 3 (230V / 50Hz) from Thermo Scientific
Horizontal Basis 1.2 (230V / 50Hz) from Thermo Scientific
Biology Products: